(AMS) American Shared Hospital - Ratings and Ratios
Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0295951059
AMS: Radiosurgery Equipment, Gamma Knife, Radiation Therapy
American Shared Hospital Services (NYSE MKT: AMS) specializes in providing advanced radiation therapy solutions, operating through two segments: Medical Equipment Leasing and Retail. The company offers equipment for Gamma Knife stereotactic radiosurgery, a precise treatment for brain tumors, arteriovenous malformations, and trigeminal neuralgia, using Leksell Gamma Knife units manufactured by Elekta. AMS also provides proton beam radiation therapy services in Orlando and Long Beach, which is notable for its precision and reduced side effects. They lease medical equipment and offer comprehensive support services, including planning, installation, reimbursement, and marketing, primarily to cancer treatment centers and hospitals worldwide. Founded in 1980, AMS is headquartered in San Francisco.
Based on technical and fundamental analysis, AMSs stock is expected to face headwinds in the next three months. The stock price is below its SMA20, SMA50, and SMA200, indicating a bearish trend. However, the low ATR of $0.09 suggests minimal volatility. Fundamentally, the low P/E ratio of 4.80 and P/B ratio of 0.71 may attract value investors, potentially leading to a rebound. The positive RoE of 14.87% indicates profitability, offering a favorable outlook despite technical challenges.
Additional Sources for AMS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AMS Stock Overview
Market Cap in USD | 19m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 1984-09-07 |
AMS Stock Ratings
Growth 5y | 48.5% |
Fundamental | 19.9% |
Dividend | 6.65% |
Rel. Strength Industry | 4.91 |
Analysts | - |
Fair Price Momentum | 2.60 USD |
Fair Price DCF | - |
AMS Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 22.2% |
AMS Growth Ratios
Growth Correlation 3m | -90% |
Growth Correlation 12m | 0.4% |
Growth Correlation 5y | 67.3% |
CAGR 5y | 15.94% |
CAGR/Max DD 5y | 0.32 |
Sharpe Ratio 12m | -0.10 |
Alpha | -2.49 |
Beta | 0.64 |
Volatility | 36.62% |
Current Volume | 5k |
Average Volume 20d | 8.9k |
As of March 15, 2025, the stock is trading at USD 2.81 with a total of 5,008 shares traded.
Over the past week, the price has changed by +2.27%, over one month by -6.02%, over three months by -19.71% and over the past year by +5.84%.
Neither. Based on ValueRay Fundamental Analyses, American Shared Hospital is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 19.93 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AMS as of March 2025 is 2.60. This means that AMS is currently overvalued and has a potential downside of -7.47%.
American Shared Hospital has no consensus analysts rating.
According to ValueRays Forecast Model, AMS American Shared Hospital will be worth about 2.8 in March 2026. The stock is currently trading at 2.81. This means that the stock has a potential upside of +0.36%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 4.9 | 72.6% |
Analysts Target Price | - | - |
ValueRay Target Price | 2.8 | 0.4% |